Neurodegenerative diseases (NDs) such as Alzheimer’s
disease,
Parkinson’s disease, and Huntington’s disease are incurable
diseases with progressive loss of neural function and require urgent
development of effective treatments. Carnosol (CL) reportedly has
a pharmacological effect in the prevention of dementia. Nevertheless,
the mechanisms of CL’s neuroprotection are not entirely clear.
The present study aimed to investigate the effects and mechanisms
of CL-mediated neuroprotection through Caenorhabditis
elegans models. First, CL restored ND protein homeostasis
via inhibiting the IIS pathway, regulating MAPK signaling, and simultaneously
activating molecular chaperone, thus inhibiting amyloid peptide (Aβ),
polyglutamine (polyQ), and α-synuclein (α-syn) deposition
and reducing protein disruption-mediated behavioral and cognitive
impairments as well as neuronal damages. Furthermore, CL could repair
mitochondrial structural damage via improving the mitochondrial membrane
protein function and mitochondrial structural homeostasis and improve
mitochondrial functional defects via increasing adenosine triphosphate
contents, mitochondrial membrane potential, and reactive oxygen species
levels, suggesting that CL could improve the ubiquitous mitochondrial
defects in NDs. More importantly, we found that CL activated mitochondrial
kinetic homeostasis related genes to improve the mitochondrial homeostasis
and dysfunction in NDs. Meanwhile, CL up-regulated unc-17, cho-1, and cha-1 genes to alleviate
Aβ-mediated cholinergic neurological disorders and activated
Notch signaling and the Wnt pathway to diminish polyQ- and α-syn-induced
ASH neurons as well as dopaminergic neuron damages. Overall, our study
clarified the beneficial anti-ND neuroprotective effects of CL in
different aspects and provided new insights into developing CL into
products with preventive and therapeutic effects on NDs.